All lobbying filings

THE MCMANUS GROUP

Lobbying for DENDREON PHARMACEUTICALS LLC · Biopharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $30,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 2

S 297
PSA Screening for HIM Act
HR 1300
PSA Screening for HIM Act

Lobbying activity 2

Health Issues

Support for S. 297/H.R. 1300 - PSA Screening for HIM Act.

Medicare/Medicaid

Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.